Opus Genetics Inc (IRD)

12:17 PM

Price action breakdown for Opus Genetics Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - newser.com

12:17 PM

10:54 AM

Real time breakdown of Opus Genetics Inc. stock performanceJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com

10:54 AM

09:55 AM

Is Opus Genetics Inc. (R3X1) stock at risk of policy regulationInsider Selling & Stepwise Trade Execution Plans - newser.com

09:55 AM

09:45 AM

Opus Genetics Inc. stock momentum explained2025 Winners & Losers & Safe Entry Momentum Tips - newser.com

09:45 AM

08:50 AM

Applying chart zones and confluence areas to Opus Genetics Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com

08:50 AM

08:11 AM

Is Opus Genetics Inc. stock a safe haven assetWeekly Stock Recap & Consistent Growth Equity Picks - newser.com

08:11 AM

03:18 AM

Can Opus Genetics Inc. stock maintain operating marginsJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com

03:18 AM

03:16 AM

Does Opus Genetics Inc. stock trade at a discount to peers2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com

03:16 AM

02:00 AM

Can Opus Genetics Inc. stock hit analyst price targetsQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com

02:00 AM

Oct 10, 2025

Opus Genetics (NASDAQ:IRD) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

How big funds are accumulating Opus Genetics Inc. (R3X1) stockJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com

Oct 10, 2025

Oct 09, 2025

Can trapped investors hope for a rebound in Opus Genetics Inc.Earnings Performance Report & Risk Managed Investment Entry Signals - newser.com

Oct 09, 2025

Oct 09, 2025

What analysts say about Opus Genetics Inc R3X1 stockCapital Gains Strategies & Exceptional Profit Portfolio - earlytimes.in

Oct 09, 2025

Oct 09, 2025

Combining machine learning predictions for Opus Genetics Inc.Analyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

What data driven models say about Opus Genetics Inc.’s futureEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Opus Genetics reports positive pediatric data from LCA5 gene therapy study - Eyes On Eyecare

Oct 06, 2025

Oct 06, 2025

Opus Genetics, Inc. (NASDAQ:IRD) Sees Large Increase in Short Interest - MarketBeat

Oct 06, 2025

Oct 06, 2025

How Opus Genetics Inc. (R3X1) stock performs in volatility spikesJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com

Oct 06, 2025

Oct 05, 2025

Using R and stats models for Opus Genetics Inc. forecastingQuarterly Trade Review & High Accuracy Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Opus Genetics Inc. stock daily chart insightsQuarterly Profit Review & Reliable Breakout Forecasts - newser.com

Oct 05, 2025

Oct 04, 2025

Opus Genetics (NASDAQ:IRD) Trading Up 4.4%Should You Buy? - MarketBeat

Oct 04, 2025

Oct 02, 2025

Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025 - GlobeNewswire

Oct 02, 2025

Oct 01, 2025

Are You Looking for a Top Momentum Pick? Why Opus Genetics, Inc. (IRD) is a Great Choice - sharewise.com

Oct 01, 2025

Oct 01, 2025

Craig-Hallum Maintains Opus Genetics(IRD.US) With Buy Rating - 富途牛牛

Oct 01, 2025

Oct 01, 2025

What drives Opus Genetics Inc stock pricePrice Gap Trading Strategies & Capitalize On Fast Trends - earlytimes.in

Oct 01, 2025

Oct 01, 2025

H.C. Wainwright reiterates Buy rating on Opus Genetics stock, citing positive data - Investing.com Canada

Oct 01, 2025

Oct 01, 2025

Why pension funds invest in Opus Genetics Inc. (R3X1) stockWeekly Profit Analysis & Real-Time Sentiment Analysis - newser.com

Oct 01, 2025

Oct 01, 2025

H.C. Wainwright Maintains Opus Genetics(IRD.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛

Oct 01, 2025

Sep 30, 2025

JonesTrading Maintains Opus Genetics(IRD.US) With Buy Rating, Maintains Target Price $6 - 富途牛牛

Sep 30, 2025

Sep 30, 2025

Opus Genetics Reports Positive Pediatric Data from - GlobeNewswire

Sep 30, 2025

Sep 30, 2025

Magnum Opus: Street drinks in LCA5 gene therapy phase I/II data - BioWorld MedTech

Sep 30, 2025

Sep 30, 2025

Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5) - GlobeNewswire

Sep 30, 2025

Sep 30, 2025

Opus Genetics Shares Encouraging Data From Inherited Retinal Degeneration Study - Nasdaq

Sep 30, 2025

Sep 30, 2025

Opus Genetics reports positive data from LCA5 gene therapy trial By Investing.com - Investing.com Australia

Sep 30, 2025

Sep 30, 2025

Opus Genetics reports positive data from LCA5 gene therapy trial - Investing.com India

Sep 30, 2025

Sep 30, 2025

Opus Genetics reports positive pediatric data from OPGx-LCA5 phase 1/2 trial in Leber congenital amaurosis type 5 (LCA5) - MarketScreener

Sep 30, 2025